Int J Clin Pharmacol Res 1990;10:75-9
Xiong M, Zhang Q, Hu W, et al
Based on the study results, official recommendations will be formulated to guide clinicians and patients in managing the discontinuation of GLP-1 medications
In the SURPASS-4 trial, tirzepatide significantly decreased blood pressure, body weight, and HbA1c, and its dual-receptor agonism improved lipid profiles, increased insulin secretion, reduced inflammation, and promoted endothelial integrity (32)
But unlike nausea which can make daily life miserable, constipation typically responds quickly to simple interventions
Diabetes Care 43 , 13521355 (2020)